Evidence map›Paper›PMID 39036015›Full record

ArticleThe Pan African medical journal2024

Vitamin B12 deficiency presenting as progressive blindness in a 33-year-old HIV-positive female patient on Efavirenz-based regimen: case report.

Gloria Lubega, Joseph Lutaakome, Moses Kibirige, Daniel Opoka, Immaculate Atukunda, Eugene Ruzagira

Abstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gloria LubegaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Joseph LutaakomeMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Moses KibirigeMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Daniel OpokaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Immaculate AtukundaMakerere University, College of Health Sciences, Department of Ophthalmology, Kampala, Uganda.
Eugene RuzagiraMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optic neuritis is a rare presentation of vitamin B12 deficiency. We describe a 33-year-old female patient living with HIV presenting with progressive loss of vision for 1 week. She had a history of severe peripheral neuropathy that was managed with vitamin B12-containing tablets approximately three years before presenting with progressive loss of vision. On examination, she had no perception of light in the left eye and no perception of hand motion in the right eye. The fundus in her left eye had mild blurring of disc margins. Results from tests done showed a haemoglobin of 12.9g/dl, MCV 101fl, a serum vitamin B12 of 78pmol/l, and cytomegalovirus (CMV) test showed no active disease. She was diagnosed with optic neuritis and started on 30 mg tablets of prednisolone for 1 week with slight improvement. She was then started on vitamin B12 injections 1 mg daily for 10 days and thereafter, monthly for 6 months. She reported gradual improvement and regained her sight after 5 months treatment of with Vitamin B12 injections. Ophthalmic manifestations of vitamin B12 deficiency are not common and may present without haematological signs therefore, a high index of suspicion is required for early diagnosis and management of vitamin B12 deficiency.

Indexed as

AlkynesAnti-HIV AgentsBenzoxazinesBlindnessCyclopropanesHIV InfectionsOptic NeuritisVitamin B 12Vitamin B 12 DeficiencyAdultFemaleGlucocorticoidsHumansPrednisoloneAlkynesAnti-HIV AgentsBenzoxazinesCyclopropanesefavirenzGlucocorticoidsPrednisoloneVitamin B 12case reportHIVoptic neuritisvitamin B12 deficiency

Identifiers

PMID39036015
PMCPMC11260043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.